Home / Inspections / 1007064

FDA Inspection 1007064 — Mika Saarela, MD

Mika Saarela, MD — FEI 3013144824

The FDA completed an inspection of Mika Saarela, MD on Feb 24, 2017 in Helsinki. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 24, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Helsinki (Finland)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.